Logo Image
Opinion|Videos|July 12, 2024

MajesTEC-1 and the Value of Long-Term Follow-Up Data from ASCO 2024

Dr Garfall, MD, provides further insights around the MajesTEC-1 study.

Episodes in this series

Video content above is prompted by the following:

  • Please provide your key takeaways from this study. How do these updated results impact the potential use of teclistamab in the management of RRMM?
  • What is the value of long-term follow-up data in multiple myeloma? How does this impact treatment regimens?

Related Content